IMG_1038.png
IMG_1038.png

TIRZ 10 MG

$75.00
sold out

TIRZ is a once-weekly injectable medication approved for improving blood sugar control in adults with type 2 diabetes and commonly prescribed for medical weight management. It acts as a dual GIP and GLP-1 receptor agonist, helping regulate insulin release, slow digestion, and reduce appetite, which supports both metabolic control and weight loss.

Uses & Benefits:

Lowers fasting and post-meal blood glucose

Helps reduce A1C levels

Supports significant weight loss by decreasing hunger and increasing feelings of fullness

May improve cardiometabolic markers such as waist circumference and cholesterol levels

Risks & Considerations:

Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite as the body adjusts

Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or MEN2

May increase the risk of pancreatitis or gallbladder issues

Can cause low blood sugar when combined with certain diabetes medications

Should be started and monitored by a healthcare provider, with dosing increased gradually to minimize side effects

Always discuss your medical history, current medications, and goals with a healthcare professional to determine if tirzepatide is appropriate for you.

TIRZ is a once-weekly injectable medication approved for improving blood sugar control in adults with type 2 diabetes and commonly prescribed for medical weight management. It acts as a dual GIP and GLP-1 receptor agonist, helping regulate insulin release, slow digestion, and reduce appetite, which supports both metabolic control and weight loss.

Uses & Benefits:

Lowers fasting and post-meal blood glucose

Helps reduce A1C levels

Supports significant weight loss by decreasing hunger and increasing feelings of fullness

May improve cardiometabolic markers such as waist circumference and cholesterol levels

Risks & Considerations:

Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite as the body adjusts

Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or MEN2

May increase the risk of pancreatitis or gallbladder issues

Can cause low blood sugar when combined with certain diabetes medications

Should be started and monitored by a healthcare provider, with dosing increased gradually to minimize side effects

Always discuss your medical history, current medications, and goals with a healthcare professional to determine if tirzepatide is appropriate for you.